Exelixis (NASDAQ: EXEL) reported Q3 EPS of $0.47, $0.13 better than the analyst estimate of $0.34. Revenue for the quarter came in at $539.5 million versus the consensus estimate of $489.77 million.

GUIDANCE:

Exelixis sees FY2024 revenue of $2.15-2.2 billion, versus the consensus of $2.05 billion.

For earnings history and earnings-related data on Exelixis (EXEL) click here.